Uptake of <i>DPYD</i> and <i>UGT1A1</i> testing in Italy and adherence to pharmacogenetic guidelines: A 5‐year perspective from an EQA provider
This study provides a snapshot of pharmacogenetic testing practices in Italian laboratories participating in an EQA programme. It highlights an encouraging trend toward improved accuracy and guideline adherence, reflecting increasing awareness and harmonization in clinical pharmacogenetic practice.
Authors
- Rebecca Goodall
- Simon Patton (ORCID: https://orcid.org/0000-0002-3260-6790)
- Rossana Roncato (ORCID: https://orcid.org/0000-0002-4219-6182)
- Erika Cecchin (ORCID: https://orcid.org/0000-0001-7517-7490)
- Elena Peruzzi (ORCID: https://orcid.org/0000-0003-0073-8091)
- Michael Woodcock
- Henry Thomas (ORCID: https://orcid.org/0000-0002-6189-2060)
- Samantha Perfler
- Diletta Pasin
Institutions
- University of Udine (IT)
- Galen Research (United Kingdom) (GB)
- Centro di Riferimento Oncologico (IT)
Publication Details
- Journal
- British Journal of Clinical Pharmacology
- Published
- 2025-09-04
- DOI
- https://doi.org/10.1002/bcp.70247
- Citations
- 1
- Primary Topic
- Cancer therapeutics and mechanisms
- Type
- article
- Field-Weighted Citation Impact
- 0.81
Funders
- Ministero della Salute